Skip to main content

Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes.

van den Besselaar AM, van Dam W, Sturk A, Bertina RM

Publication: Thromb Haemost (2001) • Vol 85 • Page 647-50PMID: 11341499View on PubMed

Purpose

The purpose of this paper was to determine the effects of magnesium (Mg) contamination on prothrombin time (PT) in blood specimens.

Conclusion

At concentrations found in citrate Vacutainer tubes and stoppers, Mg significantly decreased PT in normal plasma and in plasma from patients on oral anticoagulants. However, the effect of Mg was greater in plasma from patients on oral anticoagulants and when plasma contained citrate. Because the effect of Mg was greater in patients on oral anticoagulants, increasing Mg concentration resulted in decreased PT-ratios and decreased international normalized ratios (INR).

Studies (1)

Purpose

The purpose of this study was to determine the effects of Mg contamination on PT in blood and plasma specimens from patients on oral anticoagulants and normal controls. Plasma was dialyzed to remove citrate and endogenous ions prior to experimental addition of citrate and magnesium.

Summary of Findings

At concentrations found in citrate Vacutainer tubes and stoppers, Mg significantly decreased PT in normal plasma and in plasma from patients on oral anticoagulants. However, the effect of Mg was greater in plasma from patients on oral anticoagulants and when plasma contained citrate. Because the effect of Mg was greater in patients on oral anticoagulants, increasing Mg concentration resulted in decreased PT-ratios and INR. When blood specimens were collected in freshly prepared citrate without magnesium, or in citrate with magnesium added to mimic levels in Vacutainer tubes, a 0.9-6.6% decrease in INR was found.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Not specified
    Normal
  • Platforms

    MorphologyHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBiomarker level
    0.2 mmol/L Mg
    0.5 mmol/L Mg
    1.0 mmol/L Mg
    2.0 mmol/L Mg
    PreaquisitionOther drugs
    None
    Oral anticoagulants
    Biospecimen AcquisitionAnticoagulant
    None
    Sodium citrate
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Whole blood